Amanda Gonzalez Burton

Cooley advised EliseAI, an artificial intelligence company automating complex healthcare and housing systems, on the close of its $250 million Series E financing.

Cooley advised Andreessen Horowitz, a venture capital firm, as the lead investor in Fortuna Health’s $18 million Series A financing. Josh Seidenfeld, Thomas Heiser and Amanda Gonzalez Burton led the Cooley team advising Andreessen Horowitz.

Cooley advised Movable Ink, an artificial intelligence-powered personalized content platform, on its definitive agreement to be acquired by STG. The transaction is expected to close in July 2025.

Cooley advised HAYA Therapeutics, a biotechnology company pioneering precision RNA-guided regulatory genome-targeting therapeutics, on its $65 million Series A financing round. The round was led by Sofinnova Partners and Earlybird Venture Capital, with participation from Eli Lilly and Company, ATHOS, +ND Capital, Alexandria Venture Investments, and LifeLink Ventures, with additional support from existing investors Apollo Health Ventures, Longview Ventures (an affiliate of Broadview Ventures), 4see ventures, BERNINA Bioinvest and Schroders Capital.

Lawyers Danielle Gershowitz, Josh Seidenfeld, Amanda Gonzalez Burton, Kristine Kevorkova and Thomas Heiser led the Cooley team advising HAYA Therapeutics.

Cooley advised Talli on its $4 million Series Seed financing. Partner Ariel Rom led the Cooley team advising Talli, a groundbreaking digital payments platform for the legal industry.